Tomas Leanderson
Overview
Explore the profile of Tomas Leanderson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1928
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta S, Krug S, Pokkali S, Leanderson T, Isaacs J, Srikrishna G, et al.
Am J Respir Crit Care Med
. 2018 Nov;
199(3):386-389.
PMID: 30395729
No abstract available.
2.
Tahvili S, Torngren M, Holmberg D, Leanderson T, Ivars F
PLoS One
. 2018 May;
13(5):e0196598.
PMID: 29742113
Quinoline-3-carboxamides (Q compounds) are immunomodulatory compounds that have shown efficacy both in autoimmune disease and cancer. We have in here investigated the impact of one such compound, paquinimod, on the...
3.
Kallberg E, Tahvili S, Ivars F, Leanderson T
Biochem Biophys Res Commun
. 2018 Apr;
500(3):564-568.
PMID: 29679568
We show here that increased S100A8 and S100A9 protein expression is induced in spleen of animals with active inflammation or with inoculated tumors. In tumor bearing animals an increased expression...
4.
Vogl T, Stratis A, Wixler V, Voller T, Thurainayagam S, Jorch S, et al.
J Clin Invest
. 2018 Apr;
128(5):1852-1866.
PMID: 29611822
Autoimmune diseases, such as psoriasis and arthritis, show a patchy distribution of inflammation despite systemic dysregulation of adaptive immunity. Thus, additional tissue-derived signals, such as danger-associated molecular patterns (DAMPs), are...
5.
Deronic A, Tahvili S, Leanderson T, Ivars F
BMC Cancer
. 2016 Aug;
16(1):610.
PMID: 27502070
No abstract available.
6.
Deronic A, Tahvili S, Leanderson T, Ivars F
BMC Cancer
. 2016 Jul;
16:440.
PMID: 27400708
Background: Previous work has demonstrated immunomodulatory, anti-tumor, anti-metastatic and anti-angiogenic effects of the small molecule quinoline-3-carboxamide tasquinimod in pre-clinical cancer models. To better understand the anti-tumor effects of tasquinimod in...
7.
He Z, Riva M, Bjork P, Sward K, Morgelin M, Leanderson T, et al.
PLoS One
. 2016 May;
11(5):e0156377.
PMID: 27228163
The cytosolic Ca2+-binding S100A9 and S100A8 proteins form heterodimers that are primarily expressed in human neutrophils and monocytes. We have recently shown that S100A9 binds to TLR4 in vitro and...
8.
Stenstrom M, Nyhlen H, Torngren M, Liberg D, Sparre B, Tuvesson H, et al.
J Dermatol Sci
. 2016 May;
83(1):52-9.
PMID: 27156795
Background: Systemic Sclerosis (SSc) is an autoimmune disease characterized by vascular and immune dysfunction. A hallmark of SSc is the excessive accumulation of extracellular matrix in the skin and in...
9.
Lood C, Tyden H, Gullstrand B, Jonsen A, Kallberg E, Morgelin M, et al.
Arthritis Rheumatol
. 2016 Mar;
68(8):1970-80.
PMID: 26946461
Objective: Levels of S100A8/A9, a proinflammatory and prothrombotic protein complex, are increased in several diseases, and high levels predispose to cardiovascular disease (CVD). Recently, platelet S100A8/A9 synthesis was described in...
10.
Oruc Z, Oblet C, Boumediene A, Druilhe A, Pascal V, Le Rumeur E, et al.
J Am Soc Nephrol
. 2016 Jan;
27(9):2748-61.
PMID: 26825533
IgA1 mesangial deposition is the hallmark of IgA nephropathy and Henoch-Schönlein purpura, the onset of which often follows infections. Deposited IgA has been reported as polymeric, J chain associated, and...